Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQ89M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $102,064
Award facts
- Contract value 100% obligated
- $102,063.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $102,063.70 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units). The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of September 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor supplying brand-name and generic medications, vaccines, and medical devices to military and veteran healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains. This award supports the Defense Health Agency and other federal healthcare systems' operational requirements for neurological treatment medications. As a child contract under the SPE2DX vehicle, this delivery order exemplifies the company's role within DLA's pharmaceutical supply chain infrastructure serving military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DB25FQ89M?
SPE2DB25FQ89M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQ89M worth?
The government has obligated $102,064 on SPE2DB25FQ89M.
Is contract SPE2DB25FQ89M an order under another contract?
Yes. SPE2DB25FQ89M is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ89M competed?
The extent of competition for SPE2DB25FQ89M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award